ViiV Healthcare Submits New Drug Application to US FDA for the First Monthly, Injectable, Two-Drug Regimen of Cabotegravir and Rilpivirine for Treatment of HIV - Argus Press https://t.co/Sse24Cp5YD
— IDRO (@IDROOhio) April 29, 2019
from Twitter https://twitter.com/IDROOhio
April 29, 2019 at 02:41AM
No comments:
Post a Comment